A total of USD 6.7bn will be awarded to Pfizer as a result of two major government contracts the pharmaceutical giant has won from the US federal government in November. 

The first contract award was announced on 18 November. The U.S. Army Contracting Command chose Pfizer to supply 10 million doses of oral protease inhibitor drug to help combat Covid-19 for a value of USD 5.3bn (the order was then doubled by President Biden in January 2022, but no sum has been disclosed as of yet). 

Four days later, the two entities agreed on another USD 1.4bn contract for the delivery of an additional 200 million doses of Pfizer's Covid-19 vaccine for international donation. 

Both contract award announcements have received significant coverage by the media. Their cash value, the fact that they will be paid for by taxpayers’ money one way or another, and their importance in the fight against the Covid-19 pandemic have made them a key topic for everyone. Therefore, it is no surprise that they were picked up by all major media outlets. 

But did you know that alongside the two massive contracts with the US government, Pfizer has also won hundreds of other public tenders that have largely been left without coverage by the media? 

In the EEA only, Pfizer has been an awardee of more than 200 public contracts in the 3 months between 1 September 2021 and 1 December 2021. 

While it is understandable that the company’s Covid-19 products get all the media attention, Pfizer has been sought by government authorities in Spain, Poland, Romania, Belgium and other European countries for some of the other pharmaceutical products it produces. 

None of the tenders in Europe is even close to matching the size of either of the US federal contracts. Some have a value of as little as EUR 50,000 and others exceed EUR 6m. An example of the latter is a tender awarded to Pfizer for the supply of a single drug for the bodies and companies of the Puglia SSR. 

And yet, little or no information about such tenders has been discussed at length in the media. The bottom line is that the vast majority of public contract award announcements made by government institutions do not reach the wider audience, including investors. 

However, there is early evidence that government contract awards may positively influence the awardee’s stock price. Therefore, the lack of sufficient public coverage of these contracts leaves investment opportunities unexplored as investors are simply unaware of their existence.  

So is there a way to track all public contract awards a specific company has received, and always have them in an easy to understand list?  - The answer is yes.

TenderAlpha.com has created and operates a database of more than 80m public contracts from over 100 countries worldwide, with historic data ranging from 2010. 

More importantly, the data is presented in a structured, interactive platform, which enables TenderAlpha.com users to easily find the companies and contracts of interest to them. 

For more information on how you can test the product, get in touch.